English
Polski
Español
українська
русский
The most important recent advance in the treatment of liver failure
Dr Pere Ginès shares his thoughts on the most important recent advance in the treatment of liver failure.
2021-11-30
Dr Pere Ginès shares his thoughts on the most important recent advance in the treatment of liver failure.
Dr Ian Gralnek from Technion-Israel Institute of Technology shares his views on the 3 most important recent advances in gastrointestinal endoscopy.
Dr Irene Sarosiek from Texas Tech University Health Sciences Center (TTUHSC), United States, offers her view on the 3 most important recent advances in the management of GI motility disorders.
Dr Paul Moayyedi, professor of medicine from McMaster University, shares his views on the 3 most important recent advances in gastroenterology.
Is fecal microbiota transplantation (FMT) going to be performed for indications other than Clostridium difficile infection (eg, alcoholic steatohepatitis, obesity, inflammatory bowel disease [IBD])?
Can the gut microbiota lead to diseases (eg, cirrhosis or obesity)?
Is an abnormal gut microbiota a cause or consequence of inflammatory bowel disease (IBD)?
What effect do probiotics have on the gut microbiota?
What aspects of diet are beneficial for the gut microbiota?
What follow-up tests, if any, should be performed in a patient with Crohn disease who is in clinical remission?
